Research sheds important light on the metastasis of neuroblastoma

by Paul Wiggins, Children's Cancer Institute AustraliaCredit: Children's Cancer Institute AustraliaNeuroblastoma can grow and spread in the body very aggressively, making it very difficult to

Updated on: May 31,2024 7

Research sheds important light on the metastasis of neuroblastoma

by Paul Wiggins, Children's Cancer Institute AustraliaCredit: Children's Cancer Institute AustraliaNeuroblastoma can grow and spread in the body very aggressively, making it very difficult to

Updated on:May 31,2024 7

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on: February 18,2024 18

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on:February 18,2024 18

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024 15

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024 15

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on: January 30,2024 17

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on:January 30,2024 17

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on: January 29,2024 18

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on:January 29,2024 18

Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works

by Caitlin Mcdermott-Murphy,Harvard UniversityCancerous cells (dark purple) start to spread in a patient's bone marrow. Mutated genes often spark rampant AML cancer growth. Credit: The Armed

Updated on: June 15,2024 6

Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works

by Caitlin Mcdermott-Murphy,Harvard UniversityCancerous cells (dark purple) start to spread in a patient's bone marrow. Mutated genes often spark rampant AML cancer growth. Credit: The Armed

Updated on:June 15,2024 6

An AI model reveals how the body's defense system recognizes skin cancer

byUniversity of HelsinkiMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaResearchers from the University of Helsinki, HUS Comprehensive Cancer Center, A

Updated on: January 02,2024 9

An AI model reveals how the body's defense system recognizes skin cancer

byUniversity of HelsinkiMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaResearchers from the University of Helsinki, HUS Comprehensive Cancer Center, A

Updated on:January 02,2024 9

Substance use disorders on the rise for survivors of specific cancers

by Elana GotkineThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 inJAMA Oncology.Kati

Updated on: March 05,2024 16

Substance use disorders on the rise for survivors of specific cancers

by Elana GotkineThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 inJAMA Oncology.Kati

Updated on:March 05,2024 16

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on: January 22,2024 20

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on:January 22,2024 20

Financial toxicity from breast cancer treatment is common

by Lori SolomonWorldwide, breast cancer treatment is associated with substantial financial toxicity, according to a systematic review and meta-analysis published online Feb. 8 inJAMA Network Ope

Updated on: January 03,2024 9

Financial toxicity from breast cancer treatment is common

by Lori SolomonWorldwide, breast cancer treatment is associated with substantial financial toxicity, according to a systematic review and meta-analysis published online Feb. 8 inJAMA Network Ope

Updated on:January 03,2024 9

Lab-grown tumors predict treatment outcomes in landmark study

by Walter and Eliza Hall InstituteA 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell toget

Updated on: March 05,2024 10

Lab-grown tumors predict treatment outcomes in landmark study

by Walter and Eliza Hall InstituteA 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell toget

Updated on:March 05,2024 10

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on: January 22,2024 12

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on:January 22,2024 12